Zagros Darou Parsian (ZGDZ) Lifts Six-Month Net Profit 358% to 35,031 Billion Rials as Revenue Rises 3.96-Fold, 2.3 Times All of Fiscal 1404
Sahmino Newsroom | 20 November 2026 | 22 hours ago
Zagros Darou Parsian (ZGDZ) reported net profit of 35,030.5 billion rials for the six months to 31 Shahrivar 1405 (22 September 2026) in audited interim statements published on Codal on 19 November 2026 (28 Aban 1405). That compares with 7,652.2 billion rials a year earlier, an increase of 358%. Operating revenue rose from 17,976.2 billion to 71,239.8 billion rials, or 3.96-fold.
Gross profit was 42,866.3 billion rials, a gross margin of 60.2% (61.9% a year earlier). Operating profit came to 41,318.9 billion rials against 10,447.7 billion, and finance costs were 3,210.5 billion rials. Earnings per share were reported at 4,549 rials (994 rials a year earlier); capital is 7,700 billion rials. The six-month profit is 2.3 times the 15,262.3 billion rials of net profit for all of fiscal 1404 (ended 29 Esfand 1404, 20 March 2026). The figures are from the standalone income statement, and the prior-year column is marked restated.
Sahmino context
What the prices have done since this story was published, and what Sahmino wrote around it
Sahmino's reading
The close on 18 November 2026 (27 Aban 1405) was 41,020 rials, 21.8% above 33,680 rials on 24 October 2026 (2 Aban 1405) and 2.59% below its highest level in a year (42,110 rials on 16 November 2026, 25 Aban 1405). The P/E on that close is 7.15 against a sector 7.58 (nightly reading of 29 Aban 1405).
From Sahmino that week
Dividend payment: POYA
Calendar | 21 NovemberDividend payment: STIZ
Calendar | 21 NovemberThe PLSH Refinery Fund Still Trades 26% Below Its Net Asset Value, a Discount That Has Narrowed Since September (Friday 20 November 2026)
Article | 20 NovemberPrice, Not Tonnage: NALM Sold Less Aluminium Over Seven Months Yet More Than Doubled Its Sales (Thursday 19 November 2026)
Article | 19 November
More from this market
Zahravi Pharmaceutical (DZAH) Lifts Six-Month Net Profit 313% to 6,386 Billion Rials From 1,546 Billion
Stocks | 4 days agoExir Pharmaceutical (EXIR) Six-Month Profit Rises 4.5-Fold to 34,165 Billion Rials, More Than Twice All of Fiscal 1404
Stocks | 18 hours agoDarupakhsh Factories (DPAK) Lifts Six-Month Net Profit 7.2-Fold to 60,998 Billion Rials at a 66.1% Gross Margin
Stocks | 18 hours agoDarupakhsh Pharmaceutical Raw Materials (TMVD) Books 18,401 Billion Rials of Six-Month Net Profit, Up 248% and 148% of All of Fiscal 1404
Stocks | yesterday
